{"name":"BioAegis Therapeutics Inc.","slug":"bioaegis-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE93RDBzQkJOSTJycHNIaXVSZTBjU2lkS0hISDFQbXY0YXJKMXNwMi1CNzZfN0J6aWVJV1JoZTdlRVNVUm5FOTRJdDRoZ0labnpUSlRUOVhYLU05czNlOEx5MVZwU3JwWmxjRFlXamJxNzQ1eUdtN2c?oc=5","date":"2026-03-30","type":"pipeline","source":"labiotech.eu","summary":"Biotech in New Jersey, seven companies leading the charge - labiotech.eu","headline":"Biotech in New Jersey, seven companies leading the charge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxONGFpRVkwTTNZMUlaRzFxZWFVSWdhbHdOZGRTTDdVbWhueFNuRWF0X3NEa3ZLc0hzRzBwbHQ4eE1wVWFrMFlxV2NBZUlMeDJkRGJlVXkwWGp2Q2YzUFRpVUk2cXlaMjBhbkpVN2JOcjhWc3lSLWhnRHpBNE5STERPSUpJWVdMdGJ5QUpSTzgtX3NYZjMxeHpLRklvRQ?oc=5","date":"2026-03-19","type":"pipeline","source":"openPR.com","summary":"Acute Respiratory Distress Syndrome Pipeline 2026: Therapies - openPR.com","headline":"Acute Respiratory Distress Syndrome Pipeline 2026: Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxOZEd6ak10bHJYSF9CMjltajdLZEpYYXVoMi1VUXFKUDZHNi15SlQ4OTBLT2VtSDkwQmhGR3VCWDlqeERka0pEdTlqQ0VEY21WdlQyVmo1Wm54NHpTWkd2SXJoVXpLMDNpdXdnRDljWWlyQWpubmRkYWFDN3JfRC1lZS16RENfeG1VYUw0YnhfLWRubXhUYUR5ckF5U1ZiT0lUbVlhZ0lDM2VTRWZ2Ui1yZFJxVkVkYjVDOUVYU3VHNzNuYkpoMlowVUVxUzZjaTBaRzJDYzZoTFM4bWsydllfVzU1NHpNa0dDeEtGVEw2dll3UnJaM28tWXNKRnoyT09KejFzZVFfTWQyb2ZaeVF6ZVlVR2lBd3g3c2NiSDVOaGdTOHowTnVpeV9ZZFFBOW1GMGJSSDVSaklweGpxelJTZllST2U?oc=5","date":"2025-08-20","type":"regulatory","source":"GlobeNewswire","summary":"BioAegis Therapeutics Awarded Second FDA Fast Track - GlobeNewswire","headline":"BioAegis Therapeutics Awarded Second FDA Fast Track","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQRWdNNENHRGc5dVkwWUNOWW9Ka19hWVExYzVhZFJrd2xHMlVxT3RPUzdDMUlRYVNIY2xtWU9CcWZwMkhXbDJReTdRNUJreVBIMlNKTUVjZlpoVGpPQThhMW1hR1ZKR1VvS1NmYlk2eDhuSG1oLVhZeDRMT3kyZWNqWFZxcHp4bHVIOXpQMGJDS3plMXJBbUtOdGRn?oc=5","date":"2025-06-20","type":"pipeline","source":"Medical Marketing and Media","summary":"Rx Rundown: Sanofi, Processa Pharmaceuticals, Eli Lilly and more - Medical Marketing and Media","headline":"Rx Rundown: Sanofi, Processa Pharmaceuticals, Eli Lilly and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNLXo5Z0lMRkFIRHpMUG5Fb2g1YTEydGdVUHdSRTY1eXVYVmFKbmF6bF9Fei01Slp0U0sxNF96a2lyc2xKZUhtN1JoMXl3WTdTT2ZHLTN4bjhWaWsyeVBlWnJhY3p6OGFReTZSLVl2Q2JpM0hyWGgyVDJESXFHQndpRlZUa0lXS0c3engtb1p3?oc=5","date":"2025-06-17","type":"regulatory","source":"Yahoo Finance","summary":"BioAegis Therapeutics Receives FDA Fast Track Designation for Lead Product, Recombinant Human Gelsolin, for the Treatment of Acute Respiratory Distress Syndrome (ARDS) - Yahoo Finance","headline":"BioAegis Therapeutics Receives FDA Fast Track Designation for Lead Product, Recombinant Human Gelsolin, for the Treatmen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxNcF84NE13YXNXLVJrb3NScTZRR0ttRldKZXQ5SmJQd0tBZldEM0lNYWtnZW9FN1N5ZjhJVno3LUdad2tmUS1ZZ2tLZmZ2QnJ5dmsyQ1owVEc3cG0yd0hIS0dHaTYxZmN4aVNVX2YzOUhEQXBJUVp0eDQteUlXVkZac3g2eS1HdThac2l3WW90LVJfbkI4Rk12dUpOUE5fbnlUTDk4VzJTSlk0bk9kZmZHTGFsbEsxdkszWC1PdGlpamtfTGNMZ0hNdE5aUTBjaFpNamZPV0Y0X0VlMXJWc0hBTjRKZ1BRbU5IcmtURkRjb0RwTmxqXzRUdzZ4Q1dmaVQ4aXc5TFJBTU9Nc1Y0UXA1OTNiVzJ3U1lBZDEyRGNrS2JGM0tQbmVodnJVNmM?oc=5","date":"2024-12-03","type":"trial","source":"PR Newswire","summary":"Lupus Nephritis Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 30+ Companies Working in the Domain - PR Newswire","headline":"Lupus Nephritis Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 30+ C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOTkgzamNFbkxOV2ZtMU5GT3QxN0RFWGJZRFVRRXdTUG9LNi1MaGM2R2dJa1RSZkh5OUMyUEV0akdQQnBTUEhTR0VVWHJQTFdtVW5rUTJ5aVhPLTR4ajdPWW5oTXRtUG1ld3ZEWU5tVElzSHVxZDllNm5tQ1VDYU5ESjR1SHhMREVZRTM1RVR1ZFVrWGhtZHpzd3dGcW1GX01MM2dOM2dxZGVZUQ?oc=5","date":"2023-10-17","type":"pipeline","source":"Pharmaceutical Technology","summary":"BioAegis scores $20m BARDA contract to develop ARDS therapy - Pharmaceutical Technology","headline":"BioAegis scores $20m BARDA contract to develop ARDS therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPelNuMGdtM05lN1h6X0xqZW9lSnZUSElTWWZUczdIaVctaG85LWx6UnVlOGZaWC1DRWNoWnVZWTBpX0xZU0hKTjRMYkl6aTg5dGoyY0h5aUlSYXN1SjhCd2IybnFkNk5kdk96Ukw1ZHJJbmFVcGg1cVdaUlB0Mko4aA?oc=5","date":"2023-06-29","type":"pipeline","source":"Yahoo Finance","summary":"Sepsis Market Size and Share to Grow by 2032, Examines DelveInsight | Key Companies Developing Therapies - Regeneron, Merck, Shionogi, Sentien Biotechnologies, Basilea, Vivacelle Bio, Sanofi, BioAegis","headline":"Sepsis Market Size and Share to Grow by 2032, Examines DelveInsight | Key Companies Developing Therapies - Regeneron, Me","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPV2xpdXZfT1N4UWdXcmVSa1k0ZTFGdnNKZ3dEcEdxZmdYaGVWUWZzOEM0RzNQVko3bVpqNzFHOWNNdVZqRU5Fc1B5bjhrb2Q5Z2FDRGtsN09waHA4ajJBclczaUhVUHhaUE4yRkVGekJ5REV6VmVGMlgxcGdXYzFOcE9xdHd2blRPQjY4QXdsVm9rZw?oc=5","date":"2022-03-22","type":"pipeline","source":"Yahoo Finance","summary":"BioAegis Therapeutics Completes $22 Million Institutional Sale of Equity in a Non-Brokered Transaction - Yahoo Finance","headline":"BioAegis Therapeutics Completes $22 Million Institutional Sale of Equity in a Non-Brokered Transaction","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOdm40RzBiTkZ6LVVLV1ZsTmdsU3N6M3FKbzR0VGduY19Bdk96QkhTSGZnM2xlZi1wYWhQaWNIUUI1cG91bkJlWkRLcl9hR0EzZkVlUHgtTG93SzNQaUp3WE51SDJVWDB6a25mY0R5MHR6aDlTNU00RjhjbEltUWFISFFxRklOZXRwUm9ES3R3NGktUDllcFAtOEgzdnYweDFXS1hjTGgyLU9CU2pKZExSQ1hJRzlqcTdfdWxQWWJaOVp1Zw?oc=5","date":"2022-02-17","type":"pipeline","source":"citybiz","summary":"BioAegis Therapeutics Appoints Kerry Maguire and Kris Vinckier to the Corporate Board - citybiz","headline":"BioAegis Therapeutics Appoints Kerry Maguire and Kris Vinckier to the Corporate Board","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}